Triiodothyronine implant - Titan PharmaceuticalsAlternative Names: T3 implant - Titan Pharmaceuticals
Latest Information Update: 23 Jan 2017
At a glance
- Originator Titan Pharmaceuticals
- Class Amino acids; Small molecules; Thyronines
- Mechanism of Action Thyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypothyroidism
Most Recent Events
- 23 Jan 2017 Preclinical trials in Hypothyroidism in USA (SC) (Titan Pharmaceuticals pipeline, January 2017)
- 16 Nov 2015 Early research in Hypothyroidism in USA (SC)